Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PhenixFIN Corp Director's Dealing 2020

Jan 9, 2020

34218_dirs_2020-01-09_c17c32f2-56b2-45af-8fe5-c4326779840e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medley Capital Corp (MCC)
CIK: 0001490349
Period of Report: 2020-01-07

Reporting Person: Fortress Investment Group LLC (10% Owner)
Reporting Person: DB Med Investor I LLC (10% Owner)
Reporting Person: Drawbridge Special Opportunities Fund LP (10% Owner)
Reporting Person: Drawbridge Special Opportunities GP LLC (10% Owner)
Reporting Person: DRAWBRIDGE SPECIAL OPPORTUNITIES ADVISORS LLC (10% Owner)
Reporting Person: Fortress Principal Investment Holdings IV LLC (10% Owner)
Reporting Person: FIG LLC (10% Owner)
Reporting Person: Fortress Operating Entity I LP (10% Owner)
Reporting Person: FIG Corp. (10% Owner)
Reporting Person: DRAWBRIDGE SPECIAL OPPORTUNITES FUND LTD (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-07 Common Stock S 31712 $2.16 Disposed 6912060 Indirect
2020-01-08 Common Stock S 20500 $2.20 Disposed 6891560 Indirect

Footnotes

F1: The price in Column 4 is a weighted average price. The actual sale prices ranged from $2.150 to $2.190 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Each reporting person disclaims beneficial ownership of all reported shares except to the extent of its pecuniary interest therein and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for the purposes of Section 16 or otherwise. DB Med Investor I LLC, a Delaware limited liability company ("DB Med"), directly owns shares of common stock of the Issuer. Drawbridge Special Opportunities Fund LP, a Delaware limited partnership ("DBSO"), and Drawbridge Special Opportunities Fund LTD, a Cayman Islands exempted company ("DBSO Ltd."), are the members of DB Med. Drawbridge Special Opportunities GP LLC, a Delaware limited liability company ("DBSO GP"), is the general partner of DBSO and DBSO Ltd. Fortress Principal Investment Holdings IV LLC, a Delaware limited liability company ("FPI IV"), is the managing member of DBSO GP. [Footnote continues below]

F3: Drawbridge Special Opportunities Advisors LLC, a Delaware limited liability company ("DBSO Advisors"), is the investment manager of DBSO and DBSO Ltd. FIG LLC, a Delaware limited liability company, is the holder of all of the issued and outstanding interests of DBSO Advisors. Fortress Operating Entity I LP, a Delaware limited partnership ("FOE I"), is the holder of all of the issued and outstanding interests of FPI IV and the Class A member of FIG LLC. FIG Corp., a Delaware corporation, is the general partner of FOE I. Fortress Investment Group LLC, a Delaware limited liability company ("Fortress"), is the holder of all of the issued and outstanding shares of FIG Corp.

F4: The price in Column 4 is a weighted average price. The actual sale prices ranged from $2.190 to $2.215 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.